Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
What Market Value Is The Plantar Fasciitis Treatment Industry Expected To Reach By 2029, Starting From 2025 Levels?
The plantar fasciitis treatment market has demonstrated significant expansion in recent years. It is anticipated to increase from $1.68 billion in 2024 to $2.07 billion in 2025, achieving a compound annual growth rate (CAGR) of 23.7%. This historic growth can be linked to the emergence of alternative therapies, improved patient education and awareness, diverse pain management solutions, a rise in sports injuries, and the application of various physical therapy techniques.
The plantar fasciitis treatment market is projected for rapid expansion in the coming years, anticipated to reach $4.69 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 22.6%. Factors contributing to this growth over the forecast period include evolving regulatory frameworks and approvals, the adoption of patient-centric strategies, advancements in research and clinical trials, an emphasis on personalized medicine, and an increasing aging demographic. Key trends during this period are expected to encompass specialized rehabilitation methods, breakthroughs in orthopedic devices, comprehensive biomechanical research, progress in alternative therapies, and enhanced patient education and self-care initiatives.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9385&type=smp
What Are The Top Growth Drivers Impacting The Plantar Fasciitis Treatment Market Outlook?
The future expansion of the plantar fasciitis market is anticipated to be driven by an increase in obesity. Obesity, characterized by an abnormal or excessive accumulation of fat, constitutes a significant health hazard. An individual is considered overweight with a body mass index (BMI) of 25 or more, and obese if their BMI exceeds 30. Notably, the likelihood of developing plantar fasciitis is almost six times lower for a person of normal weight compared to someone with a body mass index (BMI) of 30 or higher. As an illustration, figures from 2022, published by the Centers for Disease Control and Prevention (CDC), a US government agency, show that 22 states currently report an adult obesity prevalence of 35% or higher, an increase from 19 states in 2021. Consequently, the escalating rates of obesity are fueling the expansion of the plantar fasciitis market.
What Are The Major Segment Categories Driving The Plantar Fasciitis Treatment Market Growth?
The plantar fasciitis treatmentmarket covered in this report is segmented –
1) By Type: Medication Therapy; Orthotics; Shockwave Therapy; Surgery; Other Types
2) By Diagnosis: Medical History; Physical Examination; X-Rays; Radiography; Other Diagnosis
3) By End User: Hospitals; Clinics; Other End Users
Subsegments:
1) By Medication Therapy: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs); Corticosteroids; Pain Relievers; Topical Treatments
2) By Orthotics: Custom Orthotic Inserts; Over-The-Counter Insoles; Night Splints; Heel Cups
3) By Shockwave Therapy: Radial Shockwave Therapy; Focused Shockwave Therapy
4) By Surgery: Plantar Fascia Release; Gastrocnemius Recession; Other Surgical Procedures
5) By Other Types: Physical Therapy; Massage Therapy; Stretching And Strengthening Exercises; Alternative Therapies
How Are Emerging Market Trends Shaping The Plantar Fasciitis Treatment Industry Landscape?
Technological advancements are a significant trend gaining traction in the plantar fasciitis treatment market. Major companies operating in the plantar fasciitis treatment market are innovating and deploying new technologies to transform the treatment of plantar heel pain, concurrently expanding their geographic footprint to maintain their standing. For example, in December 2022, ZetrOZ Systems, a US-based ultrasound technology manufacturing company, launched the Sam X1, which stands as the sole wireless ultrasound device with FDA certification approved for at-home usage. The Sam X1 wireless unit offers a regenerative treatment alternative for soft tissue injuries and plantar fasciitis, stimulating cellular proliferation without relying on drugs or surgery. It has shown proven effectiveness in treating a wide array of injuries, including plantar fasciitis. The ZetrOZ Sam X1 device functions by widening blood vessels to deliver increased oxygenated blood to the healing region, facilitating the elimination of waste products such as cytokine enzymes and cells, thereby accelerating the healing process.
Who Are The Prominent Global Companies Shaping The Plantar Fasciitis Treatment Market?
Major companies operating in the plantar fasciitis treatment market include Bayer AG, Superfeet Worldwide LLC, Bauerfeind AG, Ottobock SE & Co. KGaA, Shapecrunch Technology Pvt. Ltd., Sanofi SA, Eli Lilly and Company, GlaxoSmithKline plc, Pfizer Inc., Bristol-Myers Squibb Company, F. Hoffmann-La Roche Ltd., Scholl’s Wellness Co., Hanger Inc., Merck & Co. Inc., Johnson & Johnson Services Inc., Smith & Nephew plc, Arthrex Inc., DJO Global Co., Medline Industries Inc., Bird & Cronin Inc., Aetrex Worldwide Inc.
Download The Full Report For Exclusive Market Findings:
https://www.thebusinessresearchcompany.com/report/plantar-fasciitis-treatment-global-market-report
Which Regional Markets Are Contributing Most To The Plantar Fasciitis Treatment Industry Expansion?
North America was the largest region in the plantar fasciitis treatment market in 2024. The regions covered in the plantar fasciitis treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Request A Customized Version Of The Plantar Fasciitis Treatment Market Report:
https://www.thebusinessresearchcompany.com/customise?id=9385&type=smp
Browse Through More Reports Similar to the Global Plantar Fasciitis Treatment Market 2025, By The Business Research Company
Digestive Enzyme Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/digestive-enzyme-global-market-report
Smart Pills Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/smart-pills-global-market-report
Microbiomes Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/microbiomes-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model